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ABS TRACT
A novel form of biological control is being applied to the dengue virus. The agent is the maternally
transmitted bacterium Wolbachia, naturally absent from the main dengue vector, the mosquito Aedes
aegypti. Three Wolbachia-based control strategies have been proposed. One is suppression of mosquito
populations by large-scale releases of males incompatible with native females; this intervention requires
ongoing releases. The other interventions transform wild mosquito populations with Wolbachia that
spread via the frequency-dependent fitness advantage of Wolbachia-infected females; those interven-
tions potentially require just a single, local release for area-wide disease control. One of these latter
strategies uses Wolbachia that shortens mosquito life, indirectly preventing viral maturation/transmis-
sion. The other strategy uses Wolbachia that block viral transmission. All interventions can be
undermined by viral, bacterial or mosquito evolution; viral virulence in humans may also evolve. We
examine existing theory, experiments and comparative evidence to motivate predictions about evolu-
tionary outcomes. (i) The life-shortening strategy seems the most likely to be thwarted by evolution. (ii)
Mosquito suppression has a reasonable chance of working locally, at least in the short term, but long-
term success over large areas is challenging. (iii) Dengue blocking faces strong selection for viral
resistance but may well persist indefinitely at some level. Virulence evolution is not mathematically
predictable, but comparative data provide no precedent for Wolbachia increasing dengue virulence. On
balance, our analysis suggests that the considerable possible benefits of these technologies outweigh
the known negatives, but the actual risk is largely unknown.
KEYWORDS : intervention; biological control; cytoplasmic incompatibility; population suppression
Wolbachia is a maternally transmitted bacterial sym-
biont of many insects [1, 2] and has several unusual
properties that make it suitable for novel approaches
to biological control of vector-borne diseases [3–5].
First, when introduced into an uninfected species,
Wolbachia often increases the relative fitness of in-
fected females so that the infection spreads to virtual
fixation (hence it is frequently called ‘selfish’).
Second, Wolbachia is compatible with a broad range
of hosts, whereby a strain isolated from one species
can often be successfully introduced to another
species, even one distantly related [6–8]. Third,
Wolbachia produces a range of effects that can be
exploited for disease control: it can inhibit the
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growth of many other microbes in its hosts [9], it can
shorten the life of its hosts [10, 11], and it can be used
to potentially eliminate uninfected populations or
populations whose Wolbachia is incompatible with
the one being released [12, 13]. Despite these myriad
effects, relatively little is known about the underlying
mechanisms [14–16], in part because Wolbachia
cannot be cultured in vitro.
The most ambitious application yet proposed for
disease control using Wolbachia is dengue ‘elimin-
ation’. Dengue is a viral disease of humans, now
endemic on three continents, affecting approxi-
mately one-third of the human population [17, 18].
The main vector of dengue virus (DENV) is the mos-
quito Aedes aegypti, which has no native Wolbachia
infection.Wolbachiawere introduced intoAe. aegypti
with the hope of controlling DENV transmission by
shortening the life of female mosquitoes [8].
Although life-shortening was projected to have only
a small impact on mosquito demography, it could
potentially have a major effect on disease transmis-
sion by greatly reducing the number of females old
enough to transmit the virus [19, 20].
The life-shortening Wolbachia, denoted wMelPop,
was initially found in a laboratory population
of Drosophila melanogaster [21]. Initial tests of
wMelPop in Ae. aegypti raised doubts about the feasi-
bility of successful introductions in nature because
wMelPop severely reduced both viability and fecund-
ity [11, 22], making spread beyond isolated popula-
tions unlikely [23–25]. Fortuitously, it was discovered
almost concurrently that some Wolbachia interfere
with viruses and other microbes in the same host
[26, 27]. The Wolbachia variant wMel, originally found
in natural D. melanogaster populations [28], partially
blocks DENV transmission without greatly impacting
Ae. aegypti [22, 29]. Field releases in isolated towns in
northern Queensland, Australia, where DENV is not
endemic but Ae. aegypti is, have successfully trans-
formed the local Ae. aegypti populations, producing
virtual fixation of DENV-blockingWolbachia. Releases
are underway to spread this infection in nearby urban
areas, aiming for area-wide dengue control (S. L.
O’Neill, personal communication).
All else equal, decreasing DENV transmission
even slightly throughout an entire Ae. aegypti
population might have a meaningful impact on
human health due to the large number of infections
[18, 30, 31]. Yet this optimism is justified only to the
extent that evolution does not reverse the Wolbachia
effect. What can we expect or predict about evolution-
ary responses to such a wide-scale intervention? Will
dengue virus evolve to dodge the suppression? Will
the virus evolve in ways that affect disease severity?
How might Wolbachia be expected to evolve in this
new host and how will the host evolve in response to
this novel infection?
The choice of which Wolbachia strains to release is
based on beneficial effects the strains exhibit at pre-
sent. Yet these effects will likely change—evolve—after
the release, and that evolution may alter the disease-
control effectiveness of the releasedWolbachia for dec-
ades to come. Successful Wolbachia introduction is
nearly irreversible; additional Wolbachia infections
might be used to displace the initial ones [4, 32, 33],
but elimination of an infection, once established, is
likely to be difficult. Hence, anticipating evolutionary
changes of dengue–Wolbachia–mosquito interactions
is important—and comparable to anticipating the evo-
lution of resistance to pesticides and antibiotics.
FRAMEWORK
Our goal is to suggest plausible paths of evolution-
ary change as it affects Wolbachia-based control of
DENV: how likely is evolution to overturn an other-
wise successful strategy? We also consider evolution
of dengue virulence in response to these interven-
tions. Beyond these, other possible effects of re-
leases abound, spanning Ae. aegypti ecology [34],
impacts on the larger insect community interacting
with Ae. aegypti and impacts on non-dengue mi-
crobes found within this mosquito. We neglect these
latter topics for lack of evidence on which to base
predictions. Our primary concern is whether we can
anticipate success or failure of attempted dengue
reduction and whether dengue disease incidence
and effects can be predicted to change. Further-
more, we consider only the evolutionary implica-
tions of these interventions, not practical, ethical,
economic or efficacy issues related to them.
THE BASES OF PREDICTION: NATURAL
PATTERNS AND MODELS OF SELECTION
Evolutionary predictions can be founded on two
types of evidence, and our predictions will rely on
both. The most straightforward predictions are
derived from actual observed evolution—experi-
mental evolution or natural evolution (‘comparative’
evidence). In this case, the prediction is merely an
extrapolation of evolution observed in one context to
a new context. The second basis for prediction
comes from models of natural selection, such as
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those that infer the fitnesses of alternative pheno-
types in the context of specific ecologies [35]. Yet
even when a phenotypic state has clear fitness bene-
fits and the model has captured the relevant biology,
evolutionary progress remains hostage to genetic
variation. Thus, predictions of this second type re-
quire both an understanding of selection and know-
ledge of or assumptions about available genetic
variation.
Predictions about evolution in this Wolbachia–
DENV interaction are necessarily based on fragmen-
tary evidence at this early state. Apart from simple
cases like the evolution of insecticide resistance,
evolution is often so sensitive to details that the only
well-founded predictions are post hoc. If evolution in
this system is highly sensitive to details—if our cur-
rent predictions prove wrong or even prove right for
the wrong reasons—our study will clarify the diffi-
culty of making such predictions. The main hopes
for successful prediction here, despite our ignorance
of details, are ‘natural experiments’ that have been
underway for decades if not millennia and interven-
tions, analogous to pesticide applications, that im-
pose such strong selection on the virus orWolbachia
that predictable evolution is expected except in the
complete absence of relevant genetic variation. We
will focus on these seemingly simple cases, offering
predictions in advance of observed evolutionary
outcomes.
EXPECTED RESPONSES TO
INTERVENTIONS
Evolutionary responses to life-shortening: a
clear expectation of reduced impact
Selection in response to a life-shortening maternal
symbiont is aligned for both the symbiont and its
host (Table 1). Under maternal transmission,
Wolbachia should evolve to increase fitness of its
female carriers [36]. On the basis of selection alone,
therefore, we predict that Wolbachia strains
that shorten host life will evolve to attenuate life
shortening (as will their hosts), even though the
efficacy of selection may be reduced at old ages
[37]. Furthermore, any pleiotropic effects of these
Wolbachia that manifest early in the mosquito life
cycle will enhance this selection. This trajectory of
reduced Wolbachia impact been observed in labora-
tory D. simulans transfected with wMelPop [38, 39].
Also,Wolbachia in natural populations ofD. simulans
have evolved over two decades to increase host
fecundity [40]. Selection for Wolbachia to benefit
their female carriers is also supported by other ob-
servations: defending hosts against other microbes
and the obligate or near-obligate symbioses
observed in many taxa (e.g. filarial nematodes [41],
the parasitic wasp Asobara tabida [42] and various
Drosophila [43, 44]).
Those direct observations from Drosophila sug-
gest that a measurable reduction in life shortening
may well occur in a decade or less. Reductions in life-
shortening will enhance the spread of Wolbachia by
lowering the unstable equilibrium frequency above
which local infection frequencies tend to increase
[23], facilitating both local introductions and spatial
spread [24]. The negative effect on DENV transmis-
sion will be reduced and possibly eliminated as mos-
quito longevity recovers.
While host andWolbachia are selected to attenuate
life shortening, DENV would be selected to shorten
its ‘extrinsic incubation period’ (EIP), the time it
takes a mosquito that has just obtained a DENV-con-
taining blood meal to be capable of DENV transmis-
sion [45]. There must be strong selection to shorten
the EIP even in the absence of Wolbachia: daily sur-
vival rates in Ae. aegypti are on the order of 0.8–0.9,
whereas females can typically transmit DENV only
after 10 days or more ([8], cf. [20], but see [46] for
short EIPs). Given that only a small fraction of
mosquitoes live long enough to transmit DENV, se-
lection on the virus to shorten its EIP must always be
strong. The fact that a relatively long EIP persists in
nature suggests either that a short EIP is impossible
or entails a sharp decline in transmission rate; the
latter alternative is supported by recent observations
of short EIPs [46]. From these considerations, it
seems that DENV could indeed evolve to decrease
its EIP in response to life-shortening Wolbachia, but
we infer that it would reduce its transmission rate to
do so. A reduction in transmission should reduce
disease incidence, but the magnitude of effect is dif-
ficult to predict.
A wild card in these forecasts is vertical transmis-
sion of DENV from the mosquito mother to her pro-
geny. Vertical transmission would possibly allow a
mosquito to transmit a virus acquired from her
mother at an early age. Vertical transmission is ap-
parently epidemiologically insignificant [47], but
could evolve to higher levels under intervention.
There are too many unknowns about such a process
to make informed predictions, but the direction of
evolution for DENV,Wolbachia, and the mosquito all
coincide with intervention failure.
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Evolutionary responses to population
suppression are less clear, but success is
delicate
The expected evolutionary responses to Wolbachia-
based population suppression are less straightfor-
ward (Table 2). In both naturally infected and
transinfected mosquitoes, matings between
Wolbachia-infected males and uninfected females
(or females carrying an incompatibleWolbachia vari-
ant) produce embryo mortality at or near 100%. This
‘cytoplasmic incompatibility’ (CI) was first identified
in the mosquito Culex pipiens [48], and Laven [12]
demonstrated that releasing incompatible males
could eradicate an isolated disease-vector popula-
tion of Culex pipiens fatigans. This approach is
functionally analogous to the release of radiation-
induced sterile males, which has proven effective
against some but not all pest species [4, 5, 49].
In any regime that kills entire populations, there is
intense selection for escape—as learned countless
times from resistance evolution to pesticides and
antibiotics. The speed of local population collapse
under massive male releases is such that little if any
gradual evolution of escape is expected, but escape
can emerge in other ways. First, any existing mutants
capable of surviving the cytoplasmic incompatibility
will be favored outright. Second, if the sterile male
release is not large enough to extinguish the local
population, or the population extends beyond the
release site, female mating discrimination can
evolve gradually in zones of partial suppression
[50]; if practical, local genetic variation from the wild
strains could be introduced into the captive stocks to
mitigate discrimination. Third, any paternal trans-
mission ofWolbachia to viable progeny or accidental
release of the Wolbachia-bearing females from the
suppressor strain [4] will create a wild mosquito
strain no longer suppressed by that Wolbachia (in
this sense, Wolbachia-induced sterility differs funda-
mentally from the irradiated sterile male technique).
Regardless of escape mechanism, it is easily
appreciated that the attempt to suppress a large
mosquito population will face greater difficulties
than attempts to suppress small ones, and long-
term suppression will be more challenging than
short-term suppression.
In many of these scenarios, the outcome rests on
the existence of appropriate genetic variation. The
comparative data, considered next, provide a mixed
message. Over evolutionary time scales, hosts have
evolved to suppress Wolbachia-induced mortality.
During the 20th century, the mothHypolimnas bolina
evolved to suppress male killing by Wolbachia
[51, 52]. Similarly, both comparative and experimen-
tal evidence suggest that D. melanogaster has
evolved to suppress CI [53], but the age of this
Wolbachia–host association is on the order of 8000
years [54].
In contrast, despite constant selection associated
with the persistence of uninfected individuals
produced by imperfect Wolbachia transmission,
D. simulans in California has not evolved to suppress
CI over the past 20 years (about 200 generations;
[55]). Moreover, D. innubila has not evolved to sup-
press Wolbachia-induced male killing over many
thousands of generations [56]. Hence, over the time
scale of a population suppression effort, there might
well be no significant evolution in mosquitoes to
escape.
Blocking DENV: partial success expected
Some strains of Wolbachia appear to block DENV
transmission. At face value, introduction and spread
of those strains offers the hope of a profound
Table 1. Life-shortening Wolbachia
Impact on dengue Mosquito lifespan shortened so that DENV does not complete its life cycle, hence cannot be
transmitted
Selection Wolbachia and mosquitoes selected to extend female lifespan
DENV selected for faster maturation
Genetic variation Wolbachia strains vary in life-shortening effect, but variation within strains is unknown
DENV can likely evolve faster maturation but with reduced transmission
Observed evolution Wolbachia harm has evolved to reduced levels in caged and wild Drosophila simulans
Prediction Life-shortening will attenuate in as little as a decade; while life-shortening persists,
DENV will evolve faster maturation but with reduced transmission
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suppression of DENV incidence without changing
mosquito demography.
Selection
The ramifications of and expected evolution in re-
sponse to Wolbachia that block DENV are more
complicated than in either of the previous two cases
(Table 3). Selection on the virus is straightforward:
there is strong selection for viruses to avoid
blocking. Direct selection on Wolbachia to block
DENV is weak or absent.
The latter conclusion requires elaboration.
Selection should certainly favor or reinforce blocking
to the extent that viral infection reduces mosquito
female fitness (as found for DENV-2 by [57]). But for
blocking to be favored, blocking must restore female
fitness. It is not immediately obvious that virus
blocking per se benefits Wolbachia, as the virus
is observed to replicate in some tissues of the
mosquito even when transmission is blocked [58].
Furthermore, the magnitude of selection on
Wolbachia is only as strong as the net effect of
DENV on mosquito/Wolbachia fitness. If DENV in-
fection frequencies in mosquitoes are on the order of
1% [59] and the fitness reduction associated with
infection is on the order of a few percent [57], selec-
tion on Wolbachia to protect its mosquito host from
DENV is weak at best.
If direct selection on Wolbachia for blocking is
weak, indirect selection could be important. For ex-
ample, blocking DENV may be a simple mechanical
consequence of Wolbachia filling salivary gland cells
and physically limiting resources for the virus [60].
Thus, direct selection for high Wolbachia somatic
density may indirectly select for blocking.
Conversely, selection may be in the other direction:
lower somatic densities are found with more
beneficial Wolbachia and seem to follow recent
transfections [38]. Furthermore, there can be a sig-
nificant deleterious fitness effect of Wolbachia in a
new host (see also [22], on the order of 10% in field
data with wMel [29]). Thus, evolution of reduced
blocking could be rapid following an introduction.
Mechanisms of dengue-blocking and host fitness
reduction remain speculative [61], however, and
are vital for understanding Wolbachia’s pleiotropic
effects and their ramifications for evolution.
Analyses of Wolbachia-infected Ae. aegypti estab-
lished in small Australian towns for 2 years indicate
no significant attenuation of virus blocking (Frentiu
et al., submitted for publication). Those towns
lacked endemic DENV, so any possible viral adapta-
tion could not be assessed. However, the persist-
ence of DENV blocking in these populations—and
of virus blocking in natural populations of D.
melanogaster in which Wolbachia does not cause
CI—suggests that virus blocking does not require
deleterious effects on the insect host.
Despite uncertainties about the bases of DENV
blocking, the strong asymmetry in selection on
DENV versus Wolbachia supports a prediction of
viral evolutionary superiority. As will be argued next
from direct observations, there appears to be a limit
to that superiority. Countless examples of viral es-
cape from human interventions likewise favor the
verdict of viral supremacy in this case. Yet viral es-
cape from Wolbachia blocking is not assured.
Despite a near ubiquity of viral escape from single
drugs, the simultaneous use of three anti-HIV drugs
(known as HAART) seems sufficient to contain HIV
evolution of resistance within patients. Some viral
vaccines have been used globally for half a century
without any noticeable viral escape (e.g. polio, mea-
sles). The critical determinant may be the
Table 2. Population suppression
Impact on dengue Mosquitoes eliminated or reduced in number
Selection Female mosquito strongly favored to survive Wolbachia killing or avoid mating with
Wolbachia-bearing males
Genetic variation No apparent standing variation for CI resistance in D. simulans
Observed evolution Wild Drosophila have not evolved to suppress incompatibility in the short term but have in the long
term; Hypolimnas bolina evolved to resist male killing within a century, whereas D. innubila has not
Prediction Population suppression will likely remain effective over a decade or more; long-term success will be
diminished by the combination of accidental releases of females from the suppressing strain,
paternal transmission of Wolbachia, and evolution of mating discrimination. Economics of
continual release required for long-term suppression will limit applications of this technology
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‘dimensionality’ of the challenge to the virus—how
many mutations are required simultaneously to
overcome the barrier. The exact mechanism of
Wolbachia blocking of dengue is unknown, but it
seems to be multifarious [61, 62], so the blocking
could involve a multidimensional challenge to the
virus. The comparative data on DENV transmission
by Ae. albopictus, which is naturally infected with
Wolbachia, indicates that viral escape from trans-
fected Ae. aegypti is far from certain, as considered
next.
Comparative evidence
The evolutionary fate of the Wolbachia–dengue inter-
action in Ae. aegypti might be inferred from naturally
occurring Wolbachia–virus interactions: is Wolbachia
infection of a mosquito commonly associated with
inability to transmit arboviruses? The answer is
clearly no with respect to complete blocking. Culex
pipiens and Aedes albopictus are common mosquito
species that harbor Wolbachia [63–65]. Both species
are vectors for many arboviruses (as listed on the
CDC arbocat site at http://wwwn.cdc.gov/arbocat/).
Indeed, Ae. albopictus transmits DENV and has
caused dengue epidemics [47]. Aedes albopictus, with
its Wolbachia infections, is also a major vector of
chikungunya virus. Studies of chikungunya virus dy-
namics in Ae albopictus reveal a decline in Wolbachia
density as the virus life cycle enters the transmission
stage [66], as if the virus is reversing interference by
Wolbachia. None of this points toward Wolbachia
supremacy.
One limitation of these comparative data is that
they are one-sided—the fact that a mosquito harbor-
ingWolbachia transmits some viruses but not others
could indeed reflect blocking of the missing viruses.
Blocking cannot be inferred without direct experi-
ments, whereas the absence of blocking is self-
evident for the transmitted viruses. A second
limitation is that the data are qualitative, not quan-
titative. In particular, various data indicate that
‘native’Wolbachia infections reduce arbovirus trans-
mission even though they do not completely block it.
Transmission rates of West Nile virus by Culex
quinquefasciatus are reduced 2- to 3-fold by the native
Wolbachia [67]. In vitro assays of Ae. albopictus trans-
mission suggest that the native Wolbachia com-
pletely blocks DENV-2 transmission [58]. These
laboratory data corroborate meta-analyses that Ae.
albopictus has significantly lower vector-competence
for DENV than Ae. aegypti [47]. The latter study also
reviewed ‘natural experiments’ indicating that, on
islands such as Taiwan, Guam and Hawaii where
Ae. albopictus has become the dominant dengue vec-
tor, dengue epidemics are much less frequent and
less severe than on comparable islands with Ae.
aegypti transmission.
Overall, the comparative evidence offers encour-
agement that Wolbachia may provide lasting, quan-
titative reduction in transmission of some DENV
serotypes. At the same time, it seems likely that
any such blocking will not fully avoid viral escape
and may even vary with the mosquito genotype, as
does vector competence [68]. A quantitative reduc-
tion in transmission can lead to meaningful reduc-
tions in numbers of cases, so implementation of the
Wolbachia strategy should not rest on complete
blocking (see [30] as an encouraging example, but
[31] as an indication of the complexities in making
robust predictions about the impact of reduced
transmission on disease prevalence).
EVOLUTION OF DENGUE VIRULENCE IN
RESPONSE TO WOLBACHIA: NO
PREDICTION
Theoretical considerations have revealed that para-
site virulence can evolve in response to many
Table 3. Dengue blocking
Impact on dengue Virus infects but cannot disseminate from mosquito
Selection Strongly asymmetric: DENV strongly favored to escape, Wolbachia not obviously selected (directly)
to maintain blocking
Genetic variation Unknown
Observed evolution Wolbachia-infected mosquitoes transmit many human viruses but are commonly associated with
reduced viral transmission
Prediction DENV will evolve to reduce complete blocking by Wolbachia, but partial DENV blocking will persist
indefinitely
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interventions, including vaccines [69–71].Wolbachia
can alter both the viral life history in the mosquito
and the mosquito life history, and both can theoret-
ically affect evolution of viral virulence in humans
and mosquitoes. Might Wolbachia select a nastier
strain of DENV? Can we make an informed predic-
tion about evolution of DENV virulence in response
to Wolbachia?
Inference from models
The short answer is that current evolution-of-viru-
lence models cannot be relied on to confidently pre-
dict changes in dengue virulence. As background, it
is important to understand that virtually all evolu-
tion-of-virulence models assume a genetic ‘trade off’
between viral transmission and virulence; virulence
in turn is taken as host death rate. Most models
address the equilibrium virulence, the state of viru-
lence when no further evolution is favored by natural
selection, and they compare the equilibrium level of
virulence expected under alternative scenarios (e.g.
with and without intervention). Furthermore, evolu-
tion-of-virulence models typically neglect the many
environmental variables that can have profound ef-
fects on disease severity and can even alter the
course of virulence evolution (e.g. [72]).
A basic issue when applying standard evolution of
virulence models to DENV-blocking Wolbachia is
whether observed dengue virulence actually corres-
ponds to an equilibrium state as envisioned by the
models. The standard model used to study virulence
evolution is a ‘SIR’ model that counts susceptible
hosts (S), infected hosts (I) and recovered hosts
(R). A quantity critical to understanding virulence evo-
lution is the number of transmissions over the life-
time of an infected host, which is found as the ratio
(transmission rate)/(host death rate+recovery rate).
A variant with higher virulence is expected to be
favored if it increases this ratio—if the increased
death rate it causes is more than offset by its higher
transmission rate. The tradeoff dictates that it can-
not increase transmission rate without also
increasing death rate.
Applying this model to current dengue virulence
in the absence of Wolbachia interference, one would
expect a high enough human death rate per infection
to limit DENV transmission from the host. Although
accurate numbers are difficult to obtain, the mortal-
ity rate over all dengue infections appears to be
on the order of 0.001 or less ([17, 73]; http://www.
who.int/csr/disease/dengue/impact/en/); the case
fatality rate can vary several-fold over the course of
an epidemic but is still low [74]. Furthermore, recent
work suggests that the estimated number of dengue
infections is possibly 4-fold times the apparent in-
fection rate because of asymptomatic infections
[18], further depressing the case mortality rate. As
the recovery rate from DENV infections is high and
the death rate very low, the ratio for DENV lifetime
transmissions is insensitive to increases in death
rate. It follows that increases in transmission should
be favored unless they increase host mortality pro-
foundly—i.e. unless there is an extraordinarily steep
tradeoff. Such steep tradeoffs are unknown, raising
doubts about the applicability of this type of model
to explain current DENV virulence as an evolutionary
equilibrium.
The problem of predicting DENV virulence evolu-
tion goes further. A recent model of virulence evolu-
tion of an arbovirus required parameterization of
four tradeoffs affecting virulence in humans [75].
One of these tradeoffs is supported [76]: viral titer
in humans correlates positively with transmission to
mosquitoes (parameter  in their model); but that
leaves three other tradeoffs unanswered. As the au-
thors emphasized, an intervention such as dengue-
blocking Wolbachia may either favor an increase or
decrease in virulence depending on these unknown
constraints.
Comparative evidence
If Wolbachia blocking generally selects increased
virulence of arboviruses, one might expect higher
virulence in viruses transmitted from mosquitoes
infected with Wolbachia. As noted above, Wolbachia
infections of Ae. albopictus partially block DENV
transmission. For at least several decades, Ae.
albopictus has been the dominant dengue vector
on several Pacific islands and in areas of southern
Asia. As noted by Lambrechts et al. [47], dengue epi-
demics seem systematically less severe in these
areas than in comparable locales in whichAe. aegypti
is the dominant vector. Furthermore, there is no sug-
gestion that DENV has become more virulent where
Ae. albopictus is the dominant vector [47]. The
limited comparative evidence thus goes against evo-
lution of higher DENV virulence in response to
Wolbachia blocking. As pointed out by a reviewer,
evolution of virulence is a minor consideration in
areas with short-lived epidemics of DENV, where
the virus dies out between successive introductions.
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DISCUSSION
A radical effort is underway to limit and possibly
eradicate dengue virus, an arbovirus transmitted
among humans by mosquitoes of the genus Aedes.
In contrast to the standard approaches of environ-
mental dosing with chemicals, repeated introduc-
tions of short-lived biological agents, or a vaccine,
population transformation with Wolbachia aims at
long-term biological control. Local introductions of
Wolbachia have the potential to spread widely and
ultimately thwart the mosquito’s ability to transmit
the virus by either of two mechanisms, depending on
strain: (i) direct blocking of transmission or (ii)
shortening mosquito lifespan so that she cannot
mature the viral infection. Additionally, Wolbachia’s
property of cytoplasmic incompatibility in crosses of
infected males with uninfected females enables a
third intervention, (iii) depressing local mosquito
populations by releasing ‘sterile’ males. However,
this latter method requires the continual release of
lab-reared strains and thus depends on a substantial
infrastructure (e.g. [13]).
The first two methods are unusual forms of
biological control, because instead of killing the
target species, Wolbachia merely spreads in the
mosquito population and blocks DENV trans-
mission. As Wolbachia derives no obvious benefit
from reducing the mosquito’s ability to transmit
the virus, the question is whether the release of a
Wolbachia strain that currently reduces dengue
transmission will persist in this effect. Our focus is
reviewing the bases for predicting alternative
outcomes.
The following summarizes our conclusions.
(1) Evolution of reduced harmbyWolbachia. In many
interactions, Wolbachia and host evolve toward
mutualism. Use of a life-shortening Wolbachia
to kill mosquitoes before they can transmit
DENV is thus likely to provide at most only a
short-lived benefit. Because substantial fitness
costs increase the threshold frequency that
must be surpassed for Wolbachia to spread,
life-shortening Wolbachia will be relatively diffi-
cult to establish and are likely to spread slowly if
at all [24, 25]. Introducing one Wolbachia strain
may interfere with the subsequent introduction
of other strains later found to have more desir-
able qualities, so introductions should be
limited to those bacteria with a high probability
of success.
(2) Mosquito evolution in response to CI. Mating with
Wolbachia-infected males can effectively steril-
ize uninfected/incompatible females, and in-
fected-male releases can be used to suppress
mosquito populations [12, 13]. Success can be
undermined by evolution in the target mosquito
population to suppress CI, but various lines of
evidence suggest that genetic variation for
resistance to CI is sometimes absent.
Alternatively, the strategy runs a risk of failure
from even rare paternal transmission of
Wolbachia into the target species or from acci-
dental release of female mosquitoes bearing the
Wolbachia strain. Short-term success is thus
feasible, but long-term success faces several
challenges. Some mechanisms of failure can
be overcome by introducing new strains of
Wolbachia into the mosquitoes used for
suppression.
(3) Viral escape from transmission block. Some
Wolbachia block DENV transmission. The re-
lease of such a strain thus offers the possibility
of DENV eradication, if the blocking is not over-
come by viral or bacterial evolution and is in-
variant across the mosquito population. The
comparative evidence shows that some strains
of Wolbachia allow viral transmission by
mosquitoes, raising the possibility that evolu-
tion may ultimately reverse blocking. Combined
with the strong asymmetry in selection on virus
versus bacterium, the expectation is that den-
gue will evolve to overcome an absolute block to
transmission. The time course is difficult to pre-
dict from comparative data but could be on the
order of a decade or less because of the rapid
evolutionary potential of the virus. Yet compara-
tive evidence suggests that at least partial
blocking will persist long term, and the long-
term persistence of complete blocking is not
out of the question. The quantitative impact of
partial blocking on disease incidence is difficult
to predict but could be meaningful because so
many humans are at risk and dengue transmis-
sion rates tend to be relatively low [31].
(4) Changes in virulence. A concern is that a success-
ful Wolbachia intervention may select higher
virulence in DENV. At this stage, however evo-
lution of dengue virulence cannot be predicted
even qualitatively. From comparative data, no
unusually lethal viruses have been tied to
Wolbachia presence in other vectors, and epi-
demics vectored by Aedes albopictus (which
204 | Bull and Turelli Evolution, Medicine, and Public Health
harbors Wolbachia) are noted to be less severe
than those from Ae. aegypti. Although there is
no basis for predicting the evolution of higher
DENV virulence in response to virus blocking by
Wolbachia, there is likewise no sound basis for
rejecting the possibility of higher virulence evo-
lution – neither null model can be rejected.
As with most biological control agents, introduc-
tion ofWolbachia into a wild population is essentially
irreversible: the bacterium is likely to remain with the
host indefinitely (unless replaced by another
Wolbachia). However, other Wolbachia strains can
be introduced on top of existing strains, with double
infections (or incompatible infections) replacing the
single infections (e.g. [77]). Alternatively, captive
populations of the host can be cured of their
Wolbachia and infected with other strains [4].
Release of sufficient numbers of hosts infected
with another strain can cause displacement of
the original strain if the two strains are incompatible
[24, 32]. Some species exhibit a bewildering array of
Wolbachia strains, and we do not yet understand the
complexities of coexistence [78], so our views of
strain replacement are undoubtedly naı¨ve.
The Wolbachia releases underway provide a novel
opportunity to make a priori predictions about many
aspects of the near-term and long-term evolution of a
selfish bacterium, a virus, and the insect host/vector.
No doubt many similar opportunities for prediction
will be soon afforded by the release of genetically
modified organisms on what we imagine will become
a vast scale. There is considerable uncertainty in
anticipating some evolutionary consequences of
Wolbachia on dengue, but we can marshal some
evidence to identify likely outcomes, such as dengue
virus partially escaping transmission blockage and
Wolbachia quickly reducing its deleterious effects on
the mosquito. These predictions may fail, of course.
But having offered them in advance should help refine
future prediction.
acknowledgements
The authors thank A. A. Hoffmann, E. C. Holmes, T. W. Scott
and C. P. Simmons for discussion, comments and references
and S. L. O’Neill for comments and updates on the status of
releases; several reviewers helped us clarify our arguments.
Supported by NIH GM 57756 (JJB), NSF DEB 0815145 (MT)
and a grant from the Foundation for the National Institutes
of Health through the Grand Challenges in Global Health
Initiative of the Bill and Melinda Gates Foundation (M.T.).
J.J.B. receives support as the Miescher Regents Professor at
the University of Texas.
Conflict of interest: M.T. is involved in the Australian
Wolbachia effort currently underway and J.J.B. has no
connection to any Wolbachia effort.
references
1. Werren JH. Biology of Wolbachia. Annu Rev Entomol 1997;
42:587–609.
2. Zug R, Hammerstein P. Still a host of hosts for Wolbachia:
analysis of recent data suggests that 40% of terrestrial
arthropod species are infected. PLoS One 2012;7:e38544.
3. Curtis CF, Sinkins SP. Wolbachia as a possible means of
driving genes into populations. Parasitology 1998;
116(Suppl), S111–15.
4. Brelsfoard CL, Dobson SL. Short note: an update on the
utility of Wolbachia for controlling insect vectors and dis-
ease transmission. Aspac J Mol Biol Biotechnol 2011;19:
85–92.
5. McGraw EA, O’Neill SL. Beyond pesticides: new
thinking on an ancient problem. Nat Rev Microbiol 2013;
11:181–93.
6. O’Neill SL, Giordano R, Colbert AM et al. 16S rRNA phylo-
genetic analysis of the bacterial endosymbionts
associated with cytoplasmic incompatibility in insects.
Proc Natl Acad Sci USA 1992;89:2699–702.
7. Xi Z, Khoo CCH, Dobson SL.Wolbachia establishment and
invasion in an Aedes aegypti laboratory population. Science
2005;310:326–28.
8. McMeniman CJ, Lane RV, Cass BN et al. Stable introduc-
tion of a life-shortening Wolbachia infection into the mos-
quito Aedes aegypti. Science 2009;323:141–44.
9. Moreira LA, Iturbe-Ormaetxe I, Jeffery JA et al. AWolbachia
symbiont in Aedes aegypti limits infection with dengue,
Chikungunya, and Plasmodium. Cell 2009;139:1268–78.
10. Rasgon JL, Styer LM, Scott TW. Wolbachia-induced mor-
tality as a mechanism to modulate pathogen transmission
by vector arthropods. J Med Entomol 2003;40:125–32.
11. Yeap HL, Mee P, Walker T et al. Dynamics of the “popcorn”
Wolbachia infection in outbred Aedes aegypti informs pro-
spects for mosquito vector control. Genetics 2011;187:
583–95.
12. Laven H. Eradication ofCulex pipiens fatigans through cyto-
plasmic incompatibility. Nature 1967;216:383–84.
13. O’Connor L, Plichart C, Sang AC et al. Open release of male
mosquitoes infected with a wolbachia biopesticide: field
performance and infection containment. PLoS Negl Trop
Dis 2012;6:e1797.
14. Serbus LR, Casper-Lindley C, Landmann F, Sullivan W. The
genetics and cell biology of Wolbachia-host interactions.
Annu Rev Genet 2008;42:683–707.
15. Landmann F, Orsi GA, Loppin B, Sullivan W. Wolbachia-
mediated cytoplasmic incompatibility is associated with
Biological control of dengue Bull and Turelli | 205
impaired histone deposition in the male pronucleus. PLoS
Pathog 2009;5:e1000343.
16. Frentiu FD, Robinson J, Young PR et al. Wolbachia-
mediated resistance to dengue virus infection and death
at the cellular level. PLoS One 2010;5:e13398.
17. Guzman MG, Halstead SB, Artsob H et al. Dengue: a
continuing global threat. Nat Rev Microbiol 2010;8:S7–16.
18. Bhatt S, Gething PW, Brady OJ et al. The global distribution
and burden of dengue. Nature, 201;496:504–7.
19. Sinkins SP, O’Neill SL. Wolbachia as a vehicle to modify
insect populations. In: Handler, AM, James, AA (eds),
Insect Transgenesis: Methods and Applications. CRC Press,
2002, 271–87.
20. Rasgon JL, Scott TW. Impact of population age structure
on Wolbachia transgene driver efficacy: ecologically com-
plex factors and release of genetically modified
mosquitoes. Insect Biochem Mol Biol 2004;34:707–13.
21. Min KT, Benzer S. Wolbachia, normally a symbiont of
Drosophila, can be virulent, causing degeneration and early
death. Proc Natl Acad Sci USA 1997;94:10792–6.
22. Walker T, Johnson PH, Moreira LA et al. The wMel
Wolbachia strain blocks dengue and invades caged Aedes
aegypti populations. Nature 2011;476:450–3.
23. Turelli M. Cytoplasmic incompatibility in populations with
overlapping generations. Evolution 2010;64:232–41.
24. Barton NH, Turelli M. Spatial waves of advance with bi-
stable dynamics: cytoplasmic and genetic analogues of
Allee effects. Am Nat 2011;178:E48–75.
25. Schraiber JG, Kaczmarczyk AN, Kwok R et al. Constraints
on the use of lifespan-shortening Wolbachia to control
dengue fever. J Theor Biol 2012;297:26–32.
26. Hedges LM, Brownlie JC, O’Neill SL, Johnson KN. Wolba-
chia and virus protection in insects. Science 2008;322:702.
27. Teixeira L, Ferreira A, Ashburner M. The bacterial sym-
biontWolbachia induces resistance to RNA viral infections
in Drosophila melanogaster. PLoS Biol 2008;6:e2.
28. Hoffmann AA, Hercus M, Dagher H. Population dynamics
of theWolbachia infection causing cytoplasmic incompati-
bility in Drosophila melanogaster. Genetics 1998;148:
221–31.
29. Hoffmann AA, Montgomery BL, Popovici J et al. Successful
establishment of Wolbachia in Aedes populations to sup-
press dengue transmission. Nature 2011;476:454–7.
30. Hancock PA, Sinkins SP, Godfray HCJ. Strategies for
introducing Wolbachia to reduce transmission of
mosquito-borne diseases. PLoS Negl Trop Dis 2011;5:
e1024.
31. Hughes H, Britton NF. Modelling the use of Wolbachia to
control dengue fever transmission.BullMath Biol 2013;75:
796–818.
32. Kriesner P, Hoffmann AA, Lee SF et al. Rapid sequential
spread of two Wolbachia variants in east Australian.
Drosophila simulans. PLoS Pathog 2013;9:e1003607.
33. Bain G, Joshi D, Dong Y et al.Wolbachia invades Anopheles
stephensi populations and induces refractoriness to
Plasmodium infection. Science 2013;340:748–51.
34. Mains JW, Brelsfoard CL, Crain PR et al. Population im-
pacts of Wolbachia on Aedes albopictus. Ecol Appl Publ Ecol
Soc Am 2013;23:493–501.
35. Williams GC. Adaptation and Natural Selection. Princeton
University Press: Princeton, NJ, 1996.
36. Turelli M. Evolution of incompatibility-inducing microbes
and their hosts. Evolution 1994;48:1500–13.
37. Hamilton WD. The moulding of senescence by natural
selection. J Theor Biol 1966;12:12–45.
38. McGraw EA, Merritt DJ, Droller JN, O’Neill SL. Wolbachia
density and virulence attenuation after transfer into a
novel host. Proc Natl Acad Sci USA 2002;99:2918–23.
39. Carrington LB, Hoffmann AA, Weeks AR. Monitoring
long-term evolutionary changes followingWolbachia intro-
duction into a novel host: theWolbachia popcorn infection
in Drosophila simulans. Proc Biol Sci 2010;277:2059–68.
40. Weeks AR, Turelli M, Harcombe WR et al. From parasite to
mutualist: rapid evolution of Wolbachia in natural popula-
tions of Drosophila. PLoS Biol 2007;5:e114.
41. Taylor MJ, Voronin D, Johnston KL, Ford L. Wolbachia fil-
arial interactions. Cell Microbiol 2013;15:520–6.
42. Dedeine F, Vavre F, Fleury F et al. Removing symbiotic
Wolbachia bacteria specifically inhibits oogenesis in a
parasitic wasp. Proc Natl Acad Sci USA 2001;98:6247–52.
43. Miller WJ, Ehrman L, Schneider D. Infectious speciation
revisited: impact of symbiont-depletion on female fitness
and mating behavior of Drosophila paulistorum. PLoS
Pathog 2010;6:e1001214.
44. Fast EM, Toomey ME, Panaram K et al.Wolbachia enhance
Drosophila stem cell proliferation and target the germline
stem cell niche. Science 2011;334:990–2.
45. Tjaden NB, Thomas SM, Fischer D, Beierkuhnlein C.
Extrinsic incubation period of dengue: knowledge, back-
log, and applications of temperature dependence. PLoS
Negl Trop Dis 2013;7:e2207.
46. Ritchie SA, Montgomery BL, Hoffmann AA. Novel esti-
mates ofAedes aegypti (Diptera: Culicidae) population size
and adult survival based on Wolbachia releases. J Med
Entomol 2013;50:624–31.
47. Lambrechts L, Scott TW, Gubler DJ. Consequences of
the expanding global distribution of Aedes albopictus
for dengue virus transmission. PLoS Negl Trop Dis 2010;
4:e646.
48. Laven H. Crossing experiments with Culex strains.
Evolution 1951;5:370–5.
49. Gould F. Broadening the application of evolutionarily
based genetic pest management. Evolution 2008;62:
500–10.
50. Jaenike J, Dyer KA, Cornish C, Minhas MS. Asymmetrical
reinforcement andWolbachia infection inDrosophila. PLoS
Biol 2006;4:e325.
51. Hornett EA, Charlat S, Duplouy AMR et al. Evolution of
male-killer suppression in a natural population. PLoS Biol
2006;4:e283.
52. Hornett EA, Charlat S, Wedell N et al. Rapidly shifting sex
ratio across a species range.Curr Biol Cb 2009;19:1628–31.
206 | Bull and Turelli Evolution, Medicine, and Public Health
53. Hoffmann AA, Turelli M (1997) Cytoplasmic incompati-
bility in insects. In: O’Neill, SL, Hoffmann, AA, Werren, JH
(eds), Influential Passengers: Inherited Microorganisms
and Arthropod Reproduction. Oxford University Press:
Oxford, UK, 1997, 232.
54. Richardson MF, Weinert LA, Welch JJ et al. Population
genomics of the Wolbachia endosymbiont in Drosophila
melanogaster. PLoS Genet 2012;8:e1003129.
55. Carrington LB, Lipkowitz JR, Hoffmann AA, Turelli M. A re-
examination of Wolbachia-induced cytoplasmic incom-
patibility in California Drosophila simulans. PLoS One
2011;6: e22565.
56. Jaenike J, Dyer KA. No resistance to male-killing Wolbachia
after thousands of years of infection. J Evol Biol 2008;21:
1570–7.
57. Maciel-de-Freitas R, Koella JC, Lourenc¸o-de-Oliveira R.
Lower survival rate, longevity and fecundity of Aedes
aegypti (Diptera: Culicidae) females orally challenged with
dengue virus serotype 2. Trans R Soc Trop Med Hyg 2011;
105:452–8.
58. Mousson L, Zouache K, Arias-Goeta C et al. The native
Wolbachia symbionts limit transmission of dengue virus
in Aedes albopictus. PLoS Negl Trop Dis 2012;6:e1989.
59. Yoon I-K, Getis A, Aldstadt J et al. Fine scale spatio-
temporal clustering of dengue virus transmission in chil-
dren and Aedes aegypti in rural Thai villages. PLoS Negl
Trop Dis 2012;6:e1730.
60. Osborne SE, Iturbe-Ormaetxe I, Brownlie JC et al.
Antiviral protection and the importance of Wolbachia
density and tissue tropism in Drosophila simulans. Appl.
and Env. Micro. 2012;78:6922–9.
61. Caragata EP, Rance`s E, Hedges LM et al. Dietary choles-
terol modulates pathogen blocking by Wolbachia. PLoS
Pathog 2013;9:e1003459.
62. Rance`s E, Ye YH, Woolfit M et al. The relative importance
of innate immune priming in Wolbachia-mediated dengue
interference. PLoS Pathog 2012;8:e1002548.
63. Yen JH, Barr AR. New hypothesis of the cause of cytoplasmic
incompatibility in Culex pipiens L. Nature 1971;232:657–8.
64. Kambhampati S, Rai KS, Burgun SJ. Unidirectional cyto-
plasmic incompatibility in the mosquito, Aedes albopictus.
Evolution 1993;47:673–7.
65. Sinkins SP, Braig HR, O’Neill SL. Wolbachia pipientis:
bacterial density and unidirectional cytoplasmic
incompatibility between infected populations of Aedes
albopictus. Exp Parasitol 1995;81:284–91.
66. Mousson L, Martin E, Zouache K. Wolbachia modulates
Chikungunya replication in Aedes albopictus. Mol Ecol
2010;19:1953–64.
67. Glaser RL, Meola MA. The native Wolbachia endosymbi-
onts of Drosophila melanogaster and Culex quinquefasciatus
increase host resistance to West Nile virus infection. PLoS
One 2010;5:e11977.
68. Beerntsen BT, James AA, Christensen BM. Genetics of
mosquito vector competence. Microbiol Mol Biol Rev
Mmbr 2000;64:115–37.
69. Ewald PW. Evolution of Infectious Disease. Oxford
University Press: Oxford, UK, 1996.
70. Gandon S, Day T. Understanding and managing pathogen
evolution: a way forward. Trends Microbiol 2003;11:206–7,
author reply 208–9.
71. Mackinnon MJ, Gandon S, Read AF. Virulence evolution in
response to vaccination: the case of malaria. Vaccine 2008;
26(Suppl 3), C42–52.
72. Vizoso DB, Ebert D. Phenotypic plasticity of host-parasite
interactions in response to the route of infection. J Evol Biol
2005;18:911–21.
73. Word Health Organization. (1997) Dengue Haemorrhagic
Fever; Diagnosis, Treatment, Prevention, and Control.
Geneva, 1997.
74. Guzma´n MG, Kourı´ G, Halstead SB. Do escape mutants
explain rapid increases in dengue case-fatality rates within
epidemics? Lancet 2000;355:1902–3.
75. Medlock J, Luz PM, Struchiner CJ, Galvani AP. The
impact of transgenic mosquitoes on dengue viru-
lence to humans and mosquitoes. Am Nat 2009;174:
565–77.
76. Nguyen NM, Thi Hue Kien D, Tuan TV et al. Host and viral
features of human dengue cases shape the population of
infected and infectious Aedes aegypti mosquitoes. Proc
Natl Acad Sci USA 2013;110:9072–7.
77. Bordenstein SR, Werren JH. Bidirectional incompatibility
among divergent Wolbachia and incompatibility level dif-
ferences among closely related Wolbachia in Nasonia.
Heredity 2007;99:278–87.
78. Duron O, Raymond M, Weill M. Many compatible
Wolbachia strains coexist within natural populations of
Culex pipiens mosquito. Heredity 2011;106:986–93.
Biological control of dengue Bull and Turelli | 207
